← Leaderboards
Peter S Nelson
Fred Hutchinson Cancer Center
$31,175,698
Attributed
$34,511,555
Total exposure
38
Grants
29
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$75,614,306 · 39
By mechanism
P50$50,416,034 · 15
R01$15,375,908 · 11
P01$3,864,843 · 5
U01$2,939,689 · 1
RC1$996,908 · 1
P30$897,180 · 3
Top collaborators
- Owen N Witte5 shared
- Hong Wu5 shared
- Gavin Ha3 shared
- Phillip G Febbo2 shared
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateProgramsTumorResponseMalignant NeoplasmsResistanceProstateMolecularMorbidity - Disease RateBaseAndrogen ReceptorPhenotypeGrantGenomicsInstitutionPathway InteractionsPacific NorthwestDesignMetastatic Prostate CancerReceptor SignalingResistance MechanismUniversitiesResearch PersonnelOncogenic
Grant awards (155)
The Pacific Northwest Prostate Cancer SPORE$2,140,568
P50 · FY2025 · CA · contact PI
Evaluating prostate cancer phenotype and genotype classification from circulating tumor DNA as biomarkers for predicting treatment outcomes$592,110
R01 · FY2025 · CA
Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity$402,600
R01 · FY2025 · CA · contact PI
Identifying and Targeting Specific Determinants of the AR Cistrome that Drive Prostate Cancer Cell Survival and Proliferation$331,743
P01 · FY2025 · CA · contact PI
Project 4: Clinical Development of Therapeutic Strategies Targeting Damage Repair$237,841
P50 · FY2025 · CA · contact PI
Core A: Leadership and Administrative$237,841
P50 · FY2025 · CA · contact PI
Career Enhancement Program$237,840
P50 · FY2025 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$211,901
P50 · FY2025 · CA · contact PI
Prostate Cancer$85,511
P30 · FY2025 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,209,204
P50 · FY2024 · CA · contact PI
Evaluating prostate cancer phenotype and genotype classification from circulating tumor DNA as biomarkers for predicting treatment outcomes$566,644
R01 · FY2024 · CA
Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer$395,515
R01 · FY2024 · CA · contact PI
Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity$382,471
R01 · FY2024 · CA · contact PI
Core A: Leadership and Administrative$311,735
P50 · FY2024 · CA · contact PI
Project 4: Clinical Development of Therapeutic Strategies Targeting Damage Repair$283,564
P50 · FY2024 · CA · contact PI
A Prostate Cancer Dependency Map to Identify Tumor Subtype-Specific Vulnerabilities$195,415
R21 · FY2024 · CA · contact PI
Career Enhancement Program$80,455
P50 · FY2024 · CA · contact PI
Research Program: Prostate Cancer$76,182
P30 · FY2024 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,398,516
P50 · FY2023 · CA · contact PI
Evaluating prostate cancer phenotype and genotype classification from circulating tumor DNA as biomarkers for predicting treatment outcomes$596,466
R01 · FY2023 · CA
Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer$408,005
R01 · FY2023 · CA · contact PI
Project 1: Determining and Exploiting Mechanisms of AR-Mediated Suppression of Cell Proliferation and Survival$395,877
P01 · FY2023 · CA · contact PI
Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity$394,548
R01 · FY2023 · CA · contact PI
Core A: Leadership and Administrative$326,081
P50 · FY2023 · CA · contact PI
Project 4: Clinical Development of Therapeutic Strategies Targeting Damage Repair$308,123
P50 · FY2023 · CA · contact PI
A Prostate Cancer Dependency Map to Identify Tumor Subtype-Specific Vulnerabilities$246,840
R21 · FY2023 · CA · contact PI
Career Enhancement Program$81,449
P50 · FY2023 · CA · contact PI
Research Program: Prostate Cancer$76,184
P30 · FY2023 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$1,950,065
P50 · FY2022 · CA · contact PI
Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer$408,005
R01 · FY2022 · CA · contact PI
Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity$402,600
R01 · FY2022 · CA · contact PI
Project 1: Determining and Exploiting Mechanisms of AR-Mediated Suppression of Cell Proliferation and Survival$395,702
P01 · FY2022 · CA · contact PI
Core A: Leadership and Administrative Core$323,156
P50 · FY2022 · CA · contact PI
Project 4: Clinical Development of Therapeutic Strategies Targeting DNA Damage Repair$261,487
P50 · FY2022 · CA · contact PI
Research Program: Prostate Cancer$76,184
P30 · FY2022 · CA · contact PI
Developmental Research Program$67,943
P50 · FY2022 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$1,061,199
P50 · FY2021 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$1,014,522
P50 · FY2021 · CA · contact PI
Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer$408,336
R01 · FY2021 · CA · contact PI
Project 1: Determining and Exploiting Mechanisms of AR-Mediated Suppression of Cell Proliferation and Survival$366,979
P01 · FY2021 · CA · contact PI
Core A: Leadership and Administrative Core$182,354
P50 · FY2021 · CA · contact PI
Core A: Leadership and Administrative Core$152,711
P50 · FY2021 · CA · contact PI
Project 4: Clinical Development of Therapeutic Strategies Targeting DNA Damage Repair$142,859
P50 · FY2021 · CA · contact PI
Project 4: Clinical Development of Therapeutic Strategies Targeting DNA Damage Repair$130,400
P50 · FY2021 · CA · contact PI
Research Program: Prostate Cancer$71,445
P30 · FY2021 · CA · contact PI
Developmental Research Program$44,537
P50 · FY2021 · CA · contact PI
Developmental Research Program$39,099
P50 · FY2021 · CA · contact PI
Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer$7,996
R01 · FY2021 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,074,098
P50 · FY2020 · CA · contact PI
Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer$416,332
R01 · FY2020 · CA · contact PI
Project 1: Determining and Exploiting Mechanisms of AR-Mediated Suppression of Cell Proliferation and Survival$366,979
P01 · FY2020 · CA · contact PI
Project 4: Clinical Development of Therapeutic Strategies Targeting DNA Damage Repair$252,699
P50 · FY2020 · CA · contact PI
Core A: Leadership and Administrative Core$246,947
P50 · FY2020 · CA · contact PI
Developmental Research Program$83,186
P50 · FY2020 · CA · contact PI
Research Program: Prostate Cancer$76,890
P30 · FY2020 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,093,934
P50 · FY2019 · CA · contact PI
Determining and Exploiting Mechanisms of AR-Mediated Suppression of Cell Proliferation and Survival$402,600
R01 · FY2019 · CA · contact PI
Project 1: Determining and Exploiting Mechanisms of AR-Mediated Suppression of Cell Proliferation and Survival$385,729
P01 · FY2019 · CA · contact PI
Core A: Leadership and Administrative Core$329,606
P50 · FY2019 · CA · contact PI
Project 4: Clinical Development of Therapeutic Strategies Targeting DNA Damage Repair$275,381
P50 · FY2019 · CA · contact PI
Selective Androgen Receptor Modulators for the Treatment of Prostate Cancer$222,789
R21 · FY2019 · CA · contact PI
Developmental Research Program$81,839
P50 · FY2019 · CA · contact PI
Research Program: Prostate Cancer$69,361
P30 · FY2019 · CA · contact PI
Research Program: Prostate Cancer$9,134
P30 · FY2019 · CA · contact PI
Research Program: Prostate Cancer$7,406
P30 · FY2019 · CA · contact PI
Research Program: Prostate Cancer$3,702
P30 · FY2019 · CA · contact PI
Research Program: Prostate Cancer$2,889
P30 · FY2019 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,157,062
P50 · FY2018 · CA · contact PI
Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer$351,588
R01 · FY2018 · CA · contact PI
Project 4: Clinical Development of Therapeutic Strategies Targeting DNA Damage Repair$313,399
P50 · FY2018 · CA · contact PI
Core A: Leadership and Administrative Core$252,753
P50 · FY2018 · CA · contact PI
Selective Androgen Receptor Modulators for the Treatment of Prostate Cancer$191,400
R21 · FY2018 · CA · contact PI
Developmental Research Program$87,321
P50 · FY2018 · CA · contact PI
Research Program: Prostate Cancer$69,359
P30 · FY2018 · CA · contact PI
Research Program: Prostate Cancer$9,134
P30 · FY2018 · CA · contact PI
Research Program: Prostate Cancer$8,332
P30 · FY2018 · CA · contact PI
Research Program: Prostate Cancer$7,406
P30 · FY2018 · CA · contact PI
Research Program: Prostate Cancer$2,889
P30 · FY2018 · CA · contact PI
Research Program: Prostate Cancer$1,234
P30 · FY2018 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,220,357
P50 · FY2017 · CA · contact PI
Leadership and Administration$366,888
P50 · FY2017 · CA · contact PI
Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer$351,588
R01 · FY2017 · CA · contact PI
Steroid Metabolism in Castration-Resistant Prostate Cancer$316,667
P01 · FY2017 · CA · contact PI
Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment$229,623
P50 · FY2017 · CA · contact PI
Developmental Research Program$213,768
P50 · FY2017 · CA · contact PI
Research Program: Prostate Cancer$103,290
P30 · FY2017 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,161,999
P50 · FY2016 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$745,961
P50 · FY2016 · CA · contact PI
Leadership and Administration$369,253
P50 · FY2016 · CA · contact PI
Resistance to Cancer Therapeutics Through Microenvironment Damage Responses.$365,200
R01 · FY2016 · CA · contact PI
Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer$351,588
R01 · FY2016 · CA · contact PI
Steroid Metabolism in Castration-Resistant Prostate Cancer$312,309
P01 · FY2016 · CA · contact PI
Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment$229,235
P50 · FY2016 · CA · contact PI
Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment$223,285
P50 · FY2016 · CA · contact PI
Developmental Research Program$212,144
P50 · FY2016 · CA · contact PI
Research Program: Prostate Cancer$69,377
P30 · FY2016 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,185,000
P50 · FY2015 · CA · contact PI
Influences of the Microenvironment on Cancer Stem Cells$593,215
U01 · FY2015 · CA
Resistance to Cancer Therapeutics Through Microenvironment Damage Responses.$365,200
R01 · FY2015 · CA · contact PI
Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer$351,588
R01 · FY2015 · CA · contact PI
Steroid Metabolism in Castration-Resistant Prostate Cancer$308,329
P01 · FY2015 · CA · contact PI
Leadership and Administration$304,611
P50 · FY2015 · CA · contact PI
Developmental Research Program$164,472
P50 · FY2015 · CA · contact PI
Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment$163,986
P50 · FY2015 · CA · contact PI
Research Program: Prostate Cancer$71,271
P30 · FY2015 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,161,845
P50 · FY2014 · CA · contact PI
Influences of the Microenvironment on Cancer Stem Cells$579,004
U01 · FY2014 · CA
Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer$370,588
R01 · FY2014 · CA · contact PI
Resistance to Cancer Therapeutics Through Microenvironment Damage Responses.$354,244
R01 · FY2014 · CA · contact PI
Steroid Metabolism in Castration-Resistant Prostate Cancer$322,955
P01 · FY2014 · CA · contact PI
Leadership and Administration$289,452
P50 · FY2014 · CA · contact PI
Developmental Research Program$165,573
P50 · FY2014 · CA · contact PI
Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment$158,023
P50 · FY2014 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,150,500
P50 · FY2013 · CA · contact PI
Influences of the Microenvironment on Cancer Stem Cells$544,406
U01 · FY2013 · CA
Steroid Metabolism in Castration-Resistant Prostate Cancer$361,574
P01 · FY2013 · CA · contact PI
Resistance to Cancer Therapeutics Through Microenvironment Damage Responses.$343,288
R01 · FY2013 · CA · contact PI
Leadership and Administration$283,787
P50 · FY2013 · CA · contact PI
Clinical Development of Therapeutic Strategies Targeting Damage Responses in the$203,789
P50 · FY2013 · CA · contact PI
Developmental Research Program$162,375
P50 · FY2013 · CA · contact PI
Influences of the Microenvironment on Cancer Stem Cells$600,277
U01 · FY2012 · CA
The Pacific Northwest Prostate Cancer SPORE$599,996
P50 · FY2012 · CA · contact PI
Resistance to Cancer Therapeutics Through Microenvironment Damage Responses.$365,200
R01 · FY2012 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,185,000
P50 · FY2011 · CA · contact PI
Influences of the Microenvironment on Cancer Stem Cells$622,787
U01 · FY2011 · CA
The Pacific Northwest Prostate Cancer SPORE$2,300,000
P50 · FY2010 · CA · contact PI
Mechanism-based Classification and Targeting of Castration-Resistant Prostate Can$496,917
RC1 · FY2010 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,360,342
P50 · FY2009 · CA · contact PI
Mechanism-based Classification and Targeting of Castration-Resistant Prostate Can$499,991
RC1 · FY2009 · CA · contact PI
Development of a Urological CD Cell Typing System$326,110
R01 · FY2009 · DK · contact PI
IPBS Supplement$67,933
P50 · FY2009 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,360,341
P50 · FY2008 · CA · contact PI
Development of a Urological CD Cell Typing System$326,252
R01 · FY2008 · DK · contact PI
IPBS Supplement$68,982
P50 · FY2008 · CA · contact PI
The Pacific Northwest Prostate Cancer SPORE$2,360,341
P50 · FY2007 · CA · contact PI
Development of a Urological CD Cell Typing System$333,244
R01 · FY2007 · DK · contact PI
IPBS Supplement$63,498
P50 · FY2007 · CA · contact PI
Androgen Signaling in Neoplastic Prostate Growth$371,656
R01 · FY2006 · DK · contact PI
Development of a Urological CD Cell Typing System$358,495
R01 · FY2006 · DK · contact PI
Genetics of Prostate Cancer Susceptibility$561,450
R01 · FY2005 · CA
Androgen Signaling in Neoplastic Prostate Growth$380,600
R01 · FY2005 · DK
Genetics of Prostate Cancer Susceptibility$559,051
R01 · FY2004 · CA
Androgen Signaling in Neoplastic Prostate Growth$380,600
R01 · FY2004 · DK
Androgen Signaling in Neoplastic Prostate Growth$368,920
R01 · FY2003 · DK
TRANSCRIPTOME ANALYSIS IN NORMAL AND NEOPLASTIC PROSTATE$519,000
R01 · FY2002 · DK
SERINE PROTEASES IN PROSTATE CANCER METASTASIS$242,910
R01 · FY2002 · CA
MOLECULAR ALTERATIONS IN PROSTATE CANCER PROGRESSION$89,100
K08 · FY2002 · CA
CORE--GENOMIC AND PROTEIN ARRAYS$0
P01 · FY2002 · CA
NOVEL SERINE PROTEASE IN METASTATIC CANCER$0
P01 · FY2002 · CA
CORE--INFORMATICS AND GENE EXPRESSION$0
P50 · FY2002 · CA
TRANSCRIPTOME ANALYSIS IN NORMAL AND NEOPLASTIC PROSTATE$519,000
R01 · FY2001 · DK
SERINE PROTEASES IN PROSTATE CANCER METASTASIS$261,160
R01 · FY2001 · CA
MOLECULAR ALTERATIONS IN PROSTATE CANCER PROGRESSION$89,100
K08 · FY2001 · CA
TRANSCRIPTOME ANALYSIS IN NORMAL AND NEOPLASTIC PROSTATE$513,160
R01 · FY2000 · DK
MOLECULAR ALTERATIONS IN PROSTATE CANCER PROGRESSION$89,100
K08 · FY2000 · CA